EstechPharma Co. Ltd (041910) - Total Liabilities

Latest as of December 2025: ₩60.00 Billion KRW ≈ $40.66 Million USD

Based on the latest financial reports, EstechPharma Co. Ltd (041910) has total liabilities worth ₩60.00 Billion KRW (≈ $40.66 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

EstechPharma Co. Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how EstechPharma Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 041910 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

EstechPharma Co. Ltd Competitors by Total Liabilities

The table below lists competitors of EstechPharma Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Surapon Foods Public Company Limited BK:SSF	Thailand	฿1.38 Billion
Nanoveu Ltd AU:NVU	Australia	AU$1.46 Million
Destini Bhd KLSE:7212	Malaysia	RM174.48 Million
Samebest Co Ltd TWO:8489	Taiwan	NT$1.08 Billion
Topmix Berhad KLSE:0302	Malaysia	RM35.50 Million
SGC eTEC E&C Co. Ltd KQ:016250	Korea	₩987.40 Billion
Zenith Minerals Ltd AU:ZNC	Australia	AU$974.40K
Elutia Inc. NASDAQ:ELUT	USA	$34.68 Million

Liability Composition Analysis (2013–2025)

This chart breaks down EstechPharma Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EstechPharma Co. Ltd (041910) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EstechPharma Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EstechPharma Co. Ltd (2013–2025)

The table below shows the annual total liabilities of EstechPharma Co. Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩60.00 Billion ≈ $40.66 Million	+922.48%
2024-12-31	₩5.87 Billion ≈ $3.98 Million	-6.35%
2023-12-31	₩6.27 Billion ≈ $4.25 Million	-23.86%
2022-12-31	₩8.23 Billion ≈ $5.58 Million	-25.60%
2021-12-31	₩11.06 Billion ≈ $7.50 Million	-5.90%
2020-12-31	₩11.76 Billion ≈ $7.97 Million	-14.23%
2019-12-31	₩13.71 Billion ≈ $9.29 Million	+50.71%
2018-12-31	₩9.09 Billion ≈ $6.16 Million	-27.66%
2017-12-31	₩12.57 Billion ≈ $8.52 Million	-37.30%
2016-12-31	₩20.05 Billion ≈ $13.59 Million	+4.22%
2015-12-31	₩19.24 Billion ≈ $13.04 Million	-50.12%
2014-12-31	₩38.57 Billion ≈ $26.14 Million	+5.92%
2013-12-31	₩36.41 Billion ≈ $24.68 Million	--

About EstechPharma Co. Ltd

KQ:041910 Korea Pharmaceuticals

Market Cap

$42.03 Million

₩62.02 Billion KRW

Market Cap Rank

#22622 Global

#1460 in Korea

Share Price

₩5310.00

Change (1 day)

-4.15%

52-Week Range

₩5120.00 - ₩8920.00

All Time High

₩28269.41